metformin has been researched along with biguanides in 155 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 70 (45.16) | 18.7374 |
1990's | 13 (8.39) | 18.2507 |
2000's | 24 (15.48) | 29.6817 |
2010's | 42 (27.10) | 24.3611 |
2020's | 6 (3.87) | 2.80 |
Authors | Studies |
---|---|
Biron, P | 1 |
Schwandt, P; Weisweiler, P | 1 |
Eggstein, M; Luft, D; Schmülling, RM | 1 |
Teijgeler, CA; van Gestel, WJ | 1 |
Goebel, R; Pilger, E; Schmid, P | 2 |
Aro, A; Idänpään-Heikkilä, J; Korhonen, T | 1 |
Kowalik-Borówka, E; Tatoń, J | 1 |
Aro, A | 1 |
Alberti, KG; Nattrass, M | 1 |
Bartosiewicz, W; Czyzyk, A; Lao, B; Orlowska, K; Szczepanik, Z | 1 |
Morgan, DB; Wales, JK; Waters, AK | 1 |
Foltin, E; Irsigler, K; Kritz, H; Regal, H | 1 |
Bartosiewicz, W; Czyzyk, A; Lao, B; Orłowska, K; Szczepanik, Z | 1 |
Kimbel, KH | 1 |
Bolzano, K | 1 |
Bruneder, H; Klein, HJ | 1 |
Agid, R; Estève, B; Marquié, G | 1 |
Caspary, WF; Deuticke, U; Emrich, D; Reimold, W; Willms, B; Zavada, I | 1 |
Isnard, F; Lavieuville, M | 1 |
Botha, JL; Jackson, WP; Vinik, AI | 1 |
Jerums, G | 1 |
Förster, H | 1 |
Berger, W; Heierli, C; Mehnert-Aner, S; Mülly, K; Ritz, R | 1 |
Forshan, PH; Karam, JH; Matin, SB | 1 |
Madhavan, R; Sankaran, JR; Seshasaianam, C; Seshiah, V; Shanker, R; Sundaram, A; Venkataraman, S | 1 |
Aguilar, C; García, JE; Reza, A; Rull, JA | 1 |
Arieff, AI; Barr, J; Gan, SC; Pearl, RG | 1 |
Mehnert, H | 2 |
Saraiva, AM | 1 |
Bowden, CR; Jordan, AD; Marchione, CS; Maryanoff, BE; Reitz, AB; Tuman, RW | 1 |
Liang, JZ; Luo, ZT; Yang, DP | 1 |
Kenworthy, CW | 1 |
Chakrabarti, R; Fearnley, GR; Hocking, ED | 1 |
Katsilambros, N; Nierle, C; Pfeiffer, EE; Schatz, H | 1 |
Jahn, P; Kraaz, W; Loge, O; Losert, W; Schillinger, E | 2 |
Corsini, GU; Muntoni, S; Sirigu, F; Tagliamonte, P | 1 |
Lopis, S; Schneider, T | 1 |
Cucurachi, L; Cucurachi, P; Dell'Anna, A; Strata, A; Zuliani, U | 1 |
Berger, W; Eisner, M | 1 |
Gormsen, J | 1 |
Herbert, V | 1 |
Garrett, ER; Tsau, J | 1 |
Garrett, ER; Hinderling, PH; Tsau, J | 1 |
Fearnley, GR | 1 |
Bianchini, P; Bramanti, G; De Fina, V; Dell'Omodarme, G | 1 |
Lao, B; Okniński, W | 1 |
Chakrabarti, R; Evans, J; Fearnley, GR; Hocking, ED | 1 |
Beckmann, R | 1 |
Laastuen, L; Todd, WR | 1 |
Bewsher, PD; Stowers, JM | 1 |
Dérot, M; Rathery, H; Rathery, M | 1 |
Irsigler, K | 1 |
Tatoń, J | 1 |
Plauchu, M; Thevenon, P | 1 |
Haese, E | 1 |
Berger, W; Constam, GR; Siegenthaler, W | 1 |
Saito, T; Yoshida, S | 1 |
Lunetta, M; Mughini, L; Mughini, MT; Presti, C | 1 |
Adams, JF; Clark, JS; Ireland, JT; Kesson, CM; Watson, WS | 1 |
Angeli, G; Baraldi, B; Carobbio, C; Cocuzza, E; Colloredo Mels, G; D'Amore, V; Maestri, G | 1 |
Goldfine, ID; Pezzino, V; Vigneri, R; Wong, KY | 1 |
Bisesti, V; Giugliano, D; Passariello, N; Saccomanno, F; Sgambato, S | 1 |
Aro, A; Huttunen, JK; Järvinen, R; Juvonen, H; Korhonen, T; Palomäki, P; Ritala, P; Siitonen, O | 1 |
Chen, S; Stucki, JW; Ubl, JJ | 1 |
Bjelajac, A; Carson, DS; Goo, AK | 1 |
Kawamori, R; Yoshii, H | 1 |
Howes, LG; Lykos, D; Sundaresan, P | 1 |
Haupt, E; Panten, U | 1 |
Carmellini, M; Coppelli, A; Del Guerra, S; Giannarelli, R; Lorenzetti, M; Lupi, R; Marchetti, P; Mosca, F; Navalesi, R; Tellini, C | 1 |
Fujimoto, S | 2 |
Detaille, D; Devos, P; Wiernsperger, N | 1 |
McNeill, JH; Orvig, C; Thompson, KH; Woo, LC; Yuen, VG | 1 |
Kuritzky, L; Quillen, DM; Samraj, G | 1 |
André, P; Bard, JM; Charles, MA; Eschwege, E; Fruchart, JC; Juhan-Vague, I; Safar, M; Vague, P | 1 |
Arlt, W; Auchus, RJ; Miller, WL | 1 |
Inzucchi, SE | 1 |
Neye, H | 1 |
Shiba, T | 1 |
Kuroda, A; Yamasaki, Y | 1 |
Kitamura, R; Tanaka, Y | 1 |
Inoue, T; Kira, K; Nagakura, T; Saeki, T; Tanaka, I; Yamazaki, K; Yasuda, N | 2 |
Sakura, H | 1 |
Jonker, JW; Kato, Y; Kusuhara, H; Schinkel, AH; Sugiyama, Y; Wang, DS | 1 |
Grimaud, D; Ichai, C; Levraut, J; Samat-Long, C | 1 |
Lockwood, TD; Raymer, ML; Sweeney, D | 1 |
AKAZAWA, Y | 1 |
LEMARCHANT, JM; TEITELBAUM, M | 1 |
JAKSIC, Z; MICULINIC, R; SKRABALO, Z | 1 |
PUCHEGGER, R | 1 |
OKER, C | 1 |
BESSE, J; BILLAUD, L; LESTRADET, H | 1 |
Fonseca, VA; Jawa, AA | 1 |
Ishida, W; Satoh, J | 1 |
Daida, H; Kume, A; Miyazaki, T | 1 |
Chatti, O; Ghaddab, A; Ichai, C; Orban, JC | 1 |
Cai, Y; Finsi, J; Heimberg, H; Hinke, SA; Martens, GA; Pipeleers, D; Van de Casteele, M | 1 |
Miwa, T; Notoya, Y; Odawara, M; Suzuki, T | 1 |
Iwatsubo, T; Kamimura, H; Noguchi, K; Umehara, KI | 1 |
Fisman, EZ; Motro, M; Tenenbaum, A | 1 |
Pollak, M | 1 |
Anisimov, VN | 1 |
Sørensen, LK | 1 |
Kitamura, A; Komuro, S; Sogame, Y; Yabuki, M | 1 |
Beauchamp, MC; Gotlieb, WH; Pollak, M; Rosenblatt, J; Segal, ED; Yasmeen, A | 1 |
Fouladi, RF; Navali, N; Nikpour, MA; Pourabolghasem, S | 1 |
Choi, MG; Jung, JS; Kang, YJ; Kim, CH; Kim, SJ; Kim, SS; Park, SH; Ryu, OH; Sim, YB; Suh, HW | 1 |
Thompson, HJ; Thompson, MD | 1 |
Birnbaum, MJ; Chu, Q; Foretz, M; Miller, RA; Viollet, B; Xie, J | 1 |
Bakris, GL; Flynn, C | 1 |
Kopecky, C | 1 |
Au, C; Cabreiro, F; Cochemé, HM; Gems, D; Greene, ND; Leung, KY; Noori, T; Schuster, E; Vergara-Irigaray, N; Weinkove, D | 1 |
Gong, Y; Inagaki, N; Kagimura, T; Murai, M; Patel, S; Watada, H; Woerle, HJ | 1 |
Sheehan, ME; Wagner, LF | 1 |
Brejchova, J; Cahova, M; Cervinkova, Z; Drahota, Z; Endlicher, R; Kalous, M; Kazdova, L; Milerova, M; Palenickova, E; Svoboda, P; Vosahlikova, M | 1 |
Czlonkowski, A; Filipiak, KJ; Kaplon-Cieslicka, A; Opolski, G; Postula, M; Rosiak, M; Trzepla, E | 1 |
Asara, JM; German, NJ; Gonzalez-Herrera, KN; Haigis, MC; Janzer, A; Struhl, K | 1 |
Bridges, HR; Hirst, J; Jones, AJ; Pollak, MN | 1 |
Fontaine, E | 1 |
Birman, E; Blouin, MJ; Gravel, SP; Hulea, L; Pollak, M; St-Pierre, J; Toban, N; Topisirovic, I; Zakikhani, M; Zhao, Y | 1 |
Emami-Riedmaier, A; Mörike, K; Nies, AT; Schaeffeler, E; Schwab, M | 1 |
Bunting, KD; Cooper, TM; Liu, X; Qu, CK; Yu, WM; Zheng, H | 1 |
Araki, E; Broedl, UC; Kim, G; Koiwai, K; Salsali, A; Tanaka, Y; Taniguchi, A; Tanizawa, Y; Woerle, HJ | 1 |
Cabreiro, F; Pryor, R | 1 |
Alstrup, AK; Busk, M; Frøkiær, J; Jakobsen, S; Jensen, JB; Jessen, N; Munk, OL; Zois, NE | 1 |
Cui, H; Schröder, P | 1 |
Abbas, SY; Abdel-Rahman, RF; Basyouni, WM; El-Bayouki, KA | 1 |
Andreeff, M; Bornmann, W; Duque, JE; Enciso, L; Jaramillo, D; Konopleva, M; Krystal, G; Lee, JT; Lopez, C; Morales, L; Pan, R; Samudio, I; Suarez, M; Velez, J | 1 |
Futatsugi, A; Kato, Y; Kawabata, S; Masuo, Y; Nakamichi, N | 1 |
Langmaier, J; Pižl, M; Samec, Z; Záliš, S | 1 |
Lin, HK; Zhang, X | 1 |
Salehi, R; Samadi, N; Shafiei-Irannejad, V; Yousefi, B; Zarghami, N | 1 |
Abbas, SY; Aly, HF; Arafa, A; Basyouni, WM; El-Bayouk, KAM; Soliman, MS; Tohamy, WM | 1 |
Coutinho, AL; Obianom, ON; Shu, Y; Xue, F; Yang, H; Yang, W | 1 |
Inzucchi, SE; Sanchez-Rangel, E | 1 |
Bailey, CJ | 1 |
Hardie, DG; Pearson, ER; Rena, G | 1 |
Centurión, D; Gutiérrez-Lara, EJ; Navarrete-Vázquez, G; Sánchez-López, A | 1 |
Alan, L; Drahota, Z; Houstek, J; Kovalcikova, J; Kovarova, N; Mracek, T; Pecina, P; Pecinova, A; Zima, M | 1 |
Abbas, SY; Aly, HF; Arafa, A; Basyouni, WM; El Shehry, MF; El-Bayouki, KAM; Soliman, MS | 1 |
Hébrant, M; Herzog, G; Hussin, MH; Jajuli, MN; Rahim, AA; Saad, B | 1 |
Hotta, N | 1 |
Bharatam, PV; Kathuria, D; Raul, AD; Wanjari, P | 1 |
Al-Salami, H; Atlas, MD; Brown, D; Chester, J; Foster, T; Ionescu, CM; Johnston, E; Jones, M; Kovacevic, B; Kuthubutheen, J; Mikov, M; Mooranian, A; Wagle, SR; Walker, D | 1 |
Jimura, F; Kachi, N; Tamaki, H; Tsushima, H | 1 |
Blaza, JN; Bridges, HR; Chung, I; Hirst, J; Pollak, MN; Yin, Z | 1 |
Arredondo-Espinoza, EU; Balderas-Renteria, I; Carranza-Rosales, P; Espinosa-Rodriguez, BA; Mendez-Lopez, LF; Ramirez-Cabrera, MA; Ramirez-Estrada, K; Treviño-Almaguer, D | 1 |
Akai, Y; Higashino, T; Imamura, T; Ishii, H; Kubo, S; Mohri, T; Myojin, T; Nishioka, Y; Noda, T; Okada, S; Okamoto, S | 1 |
36 review(s) available for metformin and biguanides
Article | Year |
---|---|
Lactic acidosis in biguanide-treated diabetics: a review of 330 cases.
Topics: Acidosis; Biguanides; Buformin; Diabetes Complications; Diabetes Mellitus; Humans; Hypoglycemic Agents; Lactates; Metformin; Phenformin | 1978 |
Biguanide-associated lactic acidosis. Case report and review of the literature.
Topics: Acidosis, Lactic; Biguanides; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Emigration and Immigration; Humans; Indonesia; Kidney Failure, Chronic; Male; Metformin; Middle Aged; United States | 1992 |
[Biguanides in the treatment of diabetes mellitus].
Topics: Acidosis, Lactic; Biguanides; Diabetes Mellitus; Humans; Lipid Metabolism; Metformin | 1989 |
[Pharmacokinetics of blood glucose lowering biguanide derivatives].
Topics: Animals; Biguanides; Blood Glucose; Guinea Pigs; Humans; Hypoglycemic Agents; Kinetics; Metformin; Mice; Phenformin; Protein Binding; Rabbits; Rats; Species Specificity; Time Factors; Tritium | 1969 |
[Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
Topics: Aged; Ambulatory Care; Biguanides; Diabetes Mellitus; Diabetic Ketoacidosis; Drug Combinations; Female; Glyburide; Humans; Lactates; Male; Metformin; Middle Aged; Phenformin; Pyruvates; Sulfonylurea Compounds | 1980 |
Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Topics: Biguanides; Diabetes Mellitus, Type 2; Drug Interactions; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Sulfonylurea Compounds | 1996 |
[Drug therapy in subjects with impaired glucose tolerance].
Topics: Acarbose; Biguanides; Chromans; Diabetes Mellitus, Type 2; Glucose Intolerance; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Insulin Resistance; Metformin; Pioglitazone; Risk Factors; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; Troglitazone | 1996 |
Cardiovascular effects of oral hypoglycaemic drugs.
Topics: Biguanides; Diabetes Mellitus, Type 2; Glyburide; Heart; Hemodynamics; Humans; Hypoglycemic Agents; Lipoproteins; Metformin; Myocardial Contraction; Potassium Channel Blockers; Stimulation, Chemical; Sulfonylurea Compounds; Tolbutamide | 1996 |
[Value of biguanide in therapy of diabetes mellitus].
Topics: Biguanides; Blood Glucose; Contraindications; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin | 1997 |
[Therapeutic utility of biguanides in the treatment of NIDDM].
Topics: Biguanides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin | 1999 |
Improving management of type 2 diabetes mellitus: 2. Biguanides.
Topics: Biguanides; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin | 1999 |
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
Topics: Administration, Oral; Biguanides; Blood Glucose; Carbamates; Chromans; Diabetes Mellitus, Type 2; Diet; Drug Therapy, Combination; Enzyme Inhibitors; Exercise; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Piperidines; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
Topics: Animals; Biguanides; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver; Metformin | 2002 |
[Structure and mechanisms of action of biguanides].
Topics: Animals; Biguanides; Diabetes Mellitus, Type 2; Glucose; Humans; Hypoglycemic Agents; Intestinal Absorption; Lipid Peroxidation; Liver; Metformin | 2002 |
[Metformin--its regimen and effects].
Topics: Acarbose; Biguanides; Clinical Trials as Topic; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Metformin; Nateglinide; Patient Selection; Phenylalanine; Sulfonylurea Compounds; Treatment Outcome | 2002 |
[Adverse effect of biguanides].
Topics: Acidosis, Lactic; Biguanides; Diabetes Mellitus, Type 2; Gastrointestinal Diseases; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Phenformin; Vitamin B 12 Deficiency | 2002 |
[Clinical usefulness of treatment with biguanide and insulin].
Topics: Biguanides; Buformin; Clinical Trials as Topic; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Metformin; Prognosis | 2002 |
[Combination therapy with biguanides].
Topics: Acarbose; Biguanides; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Treatment Outcome; Troglitazone | 2002 |
Role of insulin secretagogues and insulin sensitizing agents in the prevention of cardiovascular disease in patients who have diabetes.
Topics: Angioplasty, Balloon, Coronary; Animals; Biguanides; Blood Pressure; Chromans; Diabetic Angiopathies; Endothelium, Vascular; Fibrinolysis; Humans; Hypoglycemic Agents; Metformin; Oxidative Stress; Postprandial Period; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Troglitazone | 2005 |
[Characteristic of metformin for treatment of impaired glucose tolerance].
Topics: Arteriosclerosis; Biguanides; Diabetes Mellitus, Type 2; Glucose; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Metformin; Randomized Controlled Trials as Topic | 2005 |
[Treatment for coronary artery disease patients with impaired glucose tolerance].
Topics: Acarbose; Biguanides; Coronary Artery Bypass; Coronary Artery Disease; Glucose Intolerance; Glycoside Hydrolase Inhibitors; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Insulin Resistance; Life Style; Metformin; Risk; Thiazolidinediones | 2005 |
[Metformin-associated lactic acidosis].
Topics: Acidosis, Lactic; Biguanides; Humans; Hypoglycemic Agents; Metformin | 2006 |
[Biguanides].
Topics: Biguanides; Humans; Hypoglycemic Agents; Metabolic Syndrome; Metformin | 2006 |
Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
Topics: Benzamides; Biguanides; Coronary Disease; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2008 |
Metformin and other biguanides in oncology: advancing the research agenda.
Topics: Animals; Antineoplastic Agents; Biguanides; Biomedical Research; Humans; Hypoglycemic Agents; Medical Oncology; Metformin; Neoplasms | 2010 |
Metformin for aging and cancer prevention.
Topics: Aging; Animals; Antineoplastic Agents; Biguanides; Caloric Restriction; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin-Like Growth Factor I; Life Expectancy; Longevity; Metformin; Neoplasms | 2010 |
A systems pharmacokinetic and pharmacodynamic approach to identify opportunities and pitfalls in energy stress-mediated chemoprevention: the use of metformin and other biguanides.
Topics: Animals; Biguanides; Chemoprevention; Energy Metabolism; Humans; Hypoglycemic Agents; Metformin; Neoplasms; Oxidative Stress | 2012 |
Noninsulin glucose-lowering agents for the treatment of patients on dialysis.
Topics: Adamantane; Biguanides; Diabetic Nephropathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Glucagon-Like Peptides; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Linagliptin; Meglumine; Metformin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Renal Dialysis; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Triazoles; Uracil; Vildagliptin | 2013 |
Use of noninsulin antidiabetic medications in hospitalized patients.
Topics: Benzamides; Biguanides; Bromocriptine; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Glycoside Hydrolase Inhibitors; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Islet Amyloid Polypeptide; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2013 |
Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?
Topics: Administration, Oral; Biguanides; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Global Health; Humans; Hypoglycemic Agents; Metformin; Neoplasms; Polymorphism, Genetic; Thiazolidinediones; Treatment Outcome | 2015 |
Repurposing metformin: an old drug with new tricks in its binding pockets.
Topics: Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Metformin; Neoplasms; Proteins | 2015 |
New insights into antidiabetic drugs: Possible applications in cancer treatment.
Topics: AMP-Activated Protein Kinase Kinases; Biguanides; Cell Proliferation; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Neoplasms; Protein Serine-Threonine Kinases; Sulfonylurea Compounds; Thiazolidinediones | 2017 |
Metformin: clinical use in type 2 diabetes.
Topics: Animals; Biguanides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin | 2017 |
The mechanisms of action of metformin.
Topics: AMP-Activated Protein Kinases; Animals; Biguanides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin | 2017 |
Biguanides: Species with versatile therapeutic applications.
Topics: Anti-Infective Agents; Antineoplastic Agents; Biguanides; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Proguanil | 2021 |
Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions.
Topics: Biguanides; Bile Acids and Salts; Chronic Disease; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Development; Humans; Hypoglycemic Agents; Metformin; Theranostic Nanomedicine | 2022 |
12 trial(s) available for metformin and biguanides
Article | Year |
---|---|
Diabetic hearts and biguanides.
Topics: Animals; Biguanides; Canada; Cardiovascular Diseases; Clinical Trials as Topic; Cyclic AMP; Diabetes Mellitus; Female; Humans; Male; Metformin; Phenformin; Placebos; Prospective Studies; Retrospective Studies | 1975 |
[Treatment of primary hyperlipoproteinemias type IV with different biguanides (author's transl)].
Topics: Biguanides; Buformin; Cholesterol; Female; Humans; Hyperlipidemias; Lipoproteins, VLDL; Male; Metformin; Middle Aged; Phenformin; Triglycerides | 1976 |
[The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
Topics: Acidosis; Biguanides; Buformin; Diabetes Mellitus; Exercise Test; Female; Humans; Lactates; Male; Metformin; Phenformin; Risk | 1978 |
Association of lactic acidosis with biguanide therapy.
Topics: Biguanides; Buformin; Depression, Chemical; Diabetes Mellitus; Humans; Lactates; Metabolic Clearance Rate; Metformin; Phenformin | 1977 |
Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
Topics: Adult; Aged; Angina Pectoris; Biguanides; Blood Coagulation Tests; Cholesterol; Ethylestrenol; Female; Fibrinogen; Humans; Intermittent Claudication; Male; Metformin; Middle Aged; Myocardial Infarction; Phenformin; Placebos; Vascular Diseases | 1967 |
HB419 (glibenclamide) in the treatment of diabetes mellitus.
Topics: Adult; Age Factors; Aged; Biguanides; Chlorpropamide; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Female; Gallbladder Diseases; Gastrointestinal Diseases; Humans; Hypoglycemic Agents; Kidney Diseases; Liver Diseases; Male; Metformin; Middle Aged; Phenformin; Sulfonamides; Tolbutamide; Urea; Vascular Diseases | 1969 |
[Biguanides in treatment of obesity. II. Controlled clinical research with placebos, metformin and phenformin in obesity with normal and reduced tolerance to carbohydrates].
Topics: Adolescent; Adult; Aged; Biguanides; Carbohydrate Metabolism; Clinical Trials as Topic; Diabetes Mellitus; Female; Humans; Male; Metformin; Middle Aged; Obesity; Phenformin; Placebos | 1968 |
Biguanides and gastric emptying in man.
Topics: Biguanides; Gastrointestinal Motility; Glucose; Humans; Hypoglycemic Agents; Indium; Intestinal Absorption; Intubation, Gastrointestinal; Metformin; Osmolar Concentration; Placebos; Radioisotope Dilution Technique; Radioisotopes; Stomach; Water | 1971 |
[Effect of metformin on glucose utilization and body weight].
Topics: Biguanides; Blood Glucose; Body Weight; Glucose; Glucose Tolerance Test; Humans; Injections, Intravenous; Lipid Metabolism; Lipids; Metformin; Obesity; Placebos; Time Factors | 1970 |
Therapeutic effects of biguanide vs. statin in polycystic ovary syndrome: a randomized clinical trial.
Topics: Adult; Anticholesteremic Agents; Biguanides; Blood Glucose; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Simvastatin; Treatment Outcome; Young Adult | 2011 |
Linagliptin provides effective, well-tolerated add-on therapy to pre-existing oral antidiabetic therapy over 1 year in Japanese patients with type 2 diabetes.
Topics: Asian People; Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Linagliptin; Male; Metformin; Middle Aged; Purines; Quinazolines; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; Treatment Outcome | 2013 |
Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Benzhydryl Compounds; Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Japan; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2015 |
107 other study(ies) available for metformin and biguanides
Article | Year |
---|---|
[Biguanides, rejection of treatment with buformin and fenformin, and restriction of indications for the use of metformin].
Topics: Biguanides; Buformin; Drug and Narcotic Control; Humans; Hypoglycemic Agents; Metformin; Netherlands; Phenformin | 1979 |
[Effect of biguanids on the lactate metabolism. Studies in diabetics under submaximal ergometric exercise (author's transl)].
Topics: Biguanides; Blood Glucose; Buformin; Diabetes Mellitus; Humans; Lactates; Male; Membrane Potentials; Metformin; Mitochondria; Phenformin; Physical Exertion; Pyruvates | 1979 |
Biguanide-induced lactic acidosis in Finland.
Topics: Acidosis; Aged; Biguanides; Finland; Humans; Hypoglycemic Agents; Lactates; Metformin; Middle Aged; Phenformin | 1979 |
[Indications and contraindications to the diabetes mellitus therapy by biguanide derivatives in the light of the metabolic and epidemiologic studies (author's transl)].
Topics: Adult; Aged; Biguanides; Buformin; Diabetes Mellitus; Humans; Metformin; Middle Aged; Phenformin | 1979 |
[Biguanides and lactic acidosis].
Topics: Acidosis; Biguanides; Buformin; Humans; Lactates; Metformin; Phenformin | 1978 |
Biguanides.
Topics: Biguanides; Buformin; Diabetes Mellitus; Humans; Hypoglycemic Agents; Lactates; Metformin; Phenformin | 1978 |
The effect of short-term administration of antidiabetic biguanide derivatives on the blood lactate levels in healthy subjects.
Topics: Adolescent; Adult; Biguanides; Blood Glucose; Buformin; Ethanol; Female; Fructose; Humans; Lactates; Male; Metformin; Middle Aged; Phenformin; Physical Exertion | 1978 |
Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas.
Topics: Adolescent; Adult; Aged; Biguanides; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Lactates; Male; Metformin; Middle Aged; Phenformin; Pyruvates; Sulfonylurea Compounds | 1978 |
[Comparison of the effects of phenformin, buformin and metformin on blood lactate level].
Topics: Biguanides; Buformin; Female; Humans; Lactates; Male; Metformin; Phenformin | 1978 |
[Biguanides].
Topics: Acidosis; Biguanides; Buformin; Humans; Metformin; Phenformin | 1978 |
[Biguanides: reasons for withdrawal of drugs and remaining indications].
Topics: Acidosis; Austria; Biguanides; Buformin; Diabetes Mellitus; Humans; Lactates; Legislation, Drug; Metformin; Obesity; Phenformin | 1978 |
[Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
Topics: Aged; Biguanides; Buformin; Diabetes Mellitus; Female; Humans; Lactates; Male; Metformin; Phenformin | 1978 |
[Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing].
Topics: Biguanides; Buformin; Diabetes Mellitus; Humans; Lactates; Metformin; Phenformin; Physical Exertion | 1978 |
[NN-dimethylbiguanide attenuates the lipid disorders of rats on an atherogenic diet].
Topics: Animals; Biguanides; Cholesterol; Cholesterol, Dietary; Depression, Chemical; Diet, Atherogenic; Dietary Fats; Fatty Acids; Hyperlipidemias; Liver; Male; Metformin; Rats; Stimulation, Chemical | 1975 |
Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides.
Topics: Biguanides; Buformin; Carbon Dioxide; Cholic Acids; Diabetes Mellitus; Doxycycline; Feces; Female; Glycocholic Acid; Humans; Male; Metformin; Middle Aged; Phenformin; Vitamin B 12 | 1977 |
[Lactic acidosis and biguanides: present state of the question in France].
Topics: Adult; Aged; Biguanides; Diabetes Mellitus; Female; France; Humans; Lactates; Male; Metformin; Middle Aged; Phenformin | 1977 |
The biguanides: action and clinical indications.
Topics: Biguanides; Diabetes Mellitus; Humans; Hyperglycemia; Metformin; Phenformin | 1976 |
[The importance of lactate acidosis as a side effect of biguanide therapy].
Topics: Acidosis; Biguanides; Buformin; Diabetes Mellitus; Drug Therapy, Combination; Ethanol; Humans; Kidney; Lactates; Liver; Metformin; Peritoneal Dialysis; Phenformin | 1976 |
[10 cases of lactic acidosis during biguanide therapy (buformin and phenformin)].
Topics: Acidosis; Biguanides; Buformin; Diabetes Mellitus; Glucagon; Humans; Lactates; Liver; Metformin; Phenformin; Shock, Cardiogenic | 1976 |
Simple elcetron capture gas chromatographic method for the determination of oral hypoglycemic biguanidis in biological fluids.
Topics: Biguanides; Buformin; Chromatography, Gas; Humans; Metformin; Phenformin | 1975 |
Effect of bed time intermediate acting insulin in NIDDM subjects refractory to a combination of sulphonylureas and biguanides.
Topics: Biguanides; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Injections, Subcutaneous; Insulin, Long-Acting; Lipids; Male; Metformin; Middle Aged; Phenformin; Sulfonylurea Compounds; Time Factors | 1992 |
Biguanide related lactic acidosis: incidence and risk factors.
Topics: Acidosis, Lactic; Adolescent; Adult; Aged; Aged, 80 and over; Biguanides; Contraindications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Emergencies; Female; Humans; Incidence; Male; Metformin; Mexico; Middle Aged; Odds Ratio; Phenformin; Prospective Studies; Retrospective Studies; Risk Factors; Sulfonylurea Compounds | 1992 |
[Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
Topics: Aged; Animals; Biguanides; Cricetinae; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide; Humans; Metformin; Rats; Sulfonylurea Compounds | 1989 |
Carbohydrate biguanides as potential hypoglycemic agents.
Topics: Administration, Oral; Animals; Biguanides; Glucose Tolerance Test; Hypoglycemic Agents; Male; Mass Spectrometry; Metformin; Monosaccharides; Phenformin; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1989 |
[Alteration of blood lactic acid levels in biguanide therapy in diabetics].
Topics: Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Humans; Lactates; Lactic Acid; Metformin; Middle Aged; Phenformin | 1985 |
Letter: Coronary care for myocardial infarction in diabetics.
Topics: Biguanides; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diet Therapy; Humans; Insulin; Metformin; Myocardial Infarction; Sulfonylurea Compounds | 1974 |
The effect of biguanides on secretion and biosynthesis of insulin in isolated pancreatic islets of rats.
Topics: Animals; Biguanides; Drug Interactions; Glucose; Glyburide; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Leucine; Male; Metformin; Oxygen Consumption; Phenformin; Rats; Rats, Inbred Strains; Tritium | 1972 |
[Animal experimental studies on the mode of action of biguanides. 1. Studies with hypoglycemia-inducing doses of biguanide].
Topics: Animals; Biguanides; Blood Glucose; Carbon Isotopes; Diaphragm; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Germ-Free Life; Gluconeogenesis; Glucose; Guinea Pigs; Hypoglycemia; Insulin; Insulin Secretion; Liver; Male; Metformin; Oxygen Consumption; Phenformin; Rats | 1972 |
[Animal experimental studies on the mode of action of biguanides. 1. Studies on non hypoglycemically acting biguanide].
Topics: Animals; Biguanides; Butanes; Carbon Dioxide; Carbon Isotopes; Diabetes Mellitus; Diaphragm; Fatty Acids, Nonesterified; Gluconeogenesis; Glucose; Glycogen; Guinea Pigs; Hexokinase; Insulin; Lactates; Liver; Metformin; Muscles; Phenformin; Pyruvates; Rats | 1972 |
[Demonstration of the mechanism of action of biguanides (author's transl)].
Topics: Animals; Biguanides; Fatty Acids; Glucose; Liver; Male; Metformin; Muscles; Oxidation-Reduction; Palmitic Acids; Phenformin; Rats | 1973 |
Fibrinolytic activity and haemagglutination inhibition immunoassays.
Topics: Adult; Aged; Biguanides; Clofibrate; Coronary Disease; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Hemostasis; Humans; Immunoassay; Immunodiffusion; Immunoelectrophoresis; Liver Cirrhosis; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Physical Exertion; Plasminogen; Prostatic Neoplasms; Stimulation, Chemical; Time Factors; Tolazamide | 1970 |
Metformin and B-12 malabsorption.
Topics: Biguanides; Intestinal Absorption; Metformin; Vitamin B 12 Deficiency | 1972 |
Diabetes mellitus--refractory obesity.
Topics: Biguanides; Diabetes Mellitus; Diet Therapy; Female; Fetal Death; Glucose Tolerance Test; Glycosuria; Humans; Insulin; Metformin; Middle Aged; Obesity; Phenformin; Pregnancy; Pregnancy in Diabetics; Sulfonylurea Compounds | 1972 |
Application of ion-pair methods to drug extraction from biological fluids. I. Quantitative determination of biguanides in urine.
Topics: Animals; Biguanides; Chemistry, Pharmaceutical; Coloring Agents; Hydrogen-Ion Concentration; Ions; Mathematics; Metformin; Phenformin; Spectrophotometry; Spectrum Analysis; Ultraviolet Rays | 1972 |
Application of ion-pair methods to drug extraction from biological fluids. II. Quantitative determination of biguanides in biological fluids and comparison of protein binding estimates.
Topics: Animals; Biguanides; Chemistry, Pharmaceutical; Cresols; Dialysis; Dogs; Erythrocytes; Filtration; Humans; Hydrogen-Ion Concentration; Ions; Mathematics; Metformin; Phenformin; Protein Binding; Solvents; Spectrophotometry | 1972 |
[Physiological and pharmacological aspects of fibrinolysis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arteriosclerosis Obliterans; Biguanides; Blood Coagulation Tests; Blood Platelets; Clofibrate; Coronary Disease; Diabetes Mellitus; Ethylestrenol; Fibrinolysis; Humans; Insulin; Metformin; Myocardial Infarction; Phenformin; Sulfonylurea Compounds; Testosterone; Thrombosis | 1971 |
[Comparative activity of some biguanides, sulfonylureas and their combinations on blood sugar and lactic acid in the guinea pig. II].
Topics: Amantadine; Animals; Biguanides; Blood Glucose; Chlorpropamide; Guinea Pigs; Lactates; Metformin; Phenformin; Sulfonylurea Compounds; Tolbutamide | 1971 |
[Effect of biguanide derivatives on blood lactic acid level in diabetics].
Topics: Adult; Aged; Biguanides; Diabetes Mellitus; Humans; Lactates; Metformin; Middle Aged; Phenformin | 1971 |
Fibrinolytic effect of biguanides.
Topics: Adult; Aged; Angina Pectoris; Arteriosclerosis Obliterans; Biguanides; Chlorpropamide; Coronary Disease; Ethylestrenol; Female; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Metformin; Methenolone; Middle Aged; Phenformin; Tolbutamide | 1968 |
[Absorption, distribution in the organism and elimination of metformin].
Topics: Animals; Biguanides; Carbon Isotopes; Chromatography, Paper; Female; Humans; Hypoglycemic Agents; Intestinal Absorption; Male; Metformin; Mice; Rats; Species Specificity | 1969 |
Rat liver glycogen-lowering activity of fed creatine--a retraction.
Topics: Animals; Biguanides; Creatine; Crystallization; Depression, Chemical; Gluconeogenesis; Guanidines; Hypoglycemic Agents; Injections, Intraperitoneal; Liver Glycogen; Male; Metformin; Phenformin; Rats; Time Factors | 1969 |
Studies on the mechanism of weight reduction by phenformin.
Topics: Biguanides; Diabetes Mellitus; Female; Humans; Metformin; Obesity; Phenformin | 1969 |
[The place of biguanides in the treatment of diabetes].
Topics: Biguanides; Diabetes Mellitus; Drug Synergism; Humans; Hypoglycemic Agents; Insulin; Metformin; Phenformin | 1970 |
[Clinical pharmacology of oral hypoglycemic drugs].
Topics: Biguanides; Humans; Hypoglycemic Agents; Metformin; Phenformin | 1968 |
[A hypoglycemizing sulfamide associated with biguanide in the treatment of type I diabetes in adults].
Topics: Adult; Age Factors; Aged; Biguanides; Diabetes Mellitus; Drug Synergism; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Tolbutamide | 1968 |
[On the clinical use of biguanides].
Topics: Aged; Biguanides; Blood Glucose; Body Weight; Cholesterol; Depression, Chemical; Diabetes Mellitus; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Fatty Liver; Humans; Hypoglycemic Agents; Insulin; Liver Glycogen; Metformin; Phenformin; Stimulation, Chemical | 1969 |
[Therapeutic possibilities in diabetes mellitus with biguanides. Clinical experiences in 122 diabetics with dimethylbiguanide(Glucophage)].
Topics: Adolescent; Adult; Biguanides; Body Weight; Chemical Phenomena; Chemistry; Diabetes Mellitus; Diet, Diabetic; Female; Glucose Tolerance Test; Humans; Insulin; Male; Metformin; Phenformin | 1966 |
Effects of biguanides on short-circuit current in frog skin.
Topics: Amiloride; Animals; Biguanides; Buformin; Galvanic Skin Response; Metformin; Mucous Membrane; Phenformin; Rana pipiens; Serous Membrane; Skin; Sodium; Time Factors | 1984 |
Malabsorption of vitamin B12 and intrinsic factor secretion during biguanide therapy.
Topics: Adult; Aged; Biguanides; Diabetes Mellitus; Female; Humans; Intrinsic Factor; Malabsorption Syndromes; Male; Metformin; Middle Aged; Phenformin; Vitamin B 12 | 1983 |
[Insulin response and lipid and purine metabolic disorders in protodiabetes: evaluation of the changes induced with hypoglycemic drug treatment].
Topics: Adult; Biguanides; Cholesterol; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Lipid Metabolism; Male; Metformin; Middle Aged; Purines; Sulfonylurea Compounds; Triglycerides; Uric Acid | 1980 |
Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.
Topics: Animals; Biguanides; Breast Neoplasms; Cell Line; Female; Fibroblasts; Humans; Insulin; Liver Neoplasms, Experimental; Lymphocytes; Metformin; Phenformin; Rats; Receptor, Insulin; Sulfonylurea Compounds | 1982 |
[Effects of some oral hypoglycemia drugs on blood levels of lactic and pyruvic acid in diabetes mellitus].
Topics: Biguanides; Diabetes Mellitus; Humans; Lactates; Metformin; Pyruvates; Sulfonylurea Compounds | 1980 |
[Biguanides in the treatment of diabetes].
Topics: Biguanides; Diabetes Mellitus; Humans; Metformin; Phenformin | 1980 |
Anti-diabetic biguanides inhibit hormone-induced intracellular Ca2+ concentration oscillations in rat hepatocytes.
Topics: Animals; Biguanides; Bucladesine; Calcium; Chlorides; Colforsin; Cyclic AMP; Glucagon; Inositol 1,4,5-Trisphosphate; Insulin; Liver; Male; Manganese Compounds; Metformin; Phenformin; Phenylephrine; Rats; Rats, Wistar; Second Messenger Systems | 1994 |
The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose.
Topics: Adolescent; Adult; Arginine; Biguanides; Cadaver; Dose-Response Relationship, Drug; Female; Glucose; Glyburide; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Metformin; Middle Aged | 1999 |
Cellular and molecular mechanisms involved in insulin's potentiation of glycogen synthase activity by metformin.
Topics: Animals; Biguanides; Enzyme Activation; Glycogen; Glycogen Synthase; Hypoglycemic Agents; Insulin; Metformin; Oocytes; Receptor, Insulin; Signal Transduction; Subcellular Fractions; Xenopus laevis | 1999 |
Vanadyl-biguanide complexes as potential synergistic insulin mimics.
Topics: Animals; Biguanides; Blood Glucose; Diabetes Mellitus, Experimental; Drug Synergism; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Male; Metformin; Phenformin; Rats; Rats, Wistar; Vanadates | 1999 |
Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study.
Topics: Abdomen; Adult; Aged; Biguanides; Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Female; Fibrinolysis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipoproteins; Male; Metformin; Middle Aged; Obesity; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Statistics as Topic; Triglycerides | 2001 |
Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase.
Topics: 3-Hydroxysteroid Dehydrogenases; Biguanides; Chromans; Cloning, Molecular; Humans; Kinetics; Metformin; Pioglitazone; Recombinant Proteins; Saccharomyces cerevisiae; Steroid 17-alpha-Hydroxylase; Steroid Hydroxylases; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Enhanced secretion of glucagon-like peptide 1 by biguanide compounds.
Topics: Animals; Biguanides; Buformin; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; In Vitro Techniques; Male; Metformin; Peptide Fragments; Phenformin; Protease Inhibitors; Protein Precursors; Pyrroles; Rats; Rats, Inbred F344; Valine | 2002 |
Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin.
Topics: Acidosis, Lactic; Animals; Biguanides; Disease Models, Animal; DNA-Binding Proteins; Hepatocytes; Host Cell Factor C1; Hypoglycemic Agents; Lactic Acid; Male; Metformin; Mice; Octamer Transcription Factor-1; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Transcription Factors | 2003 |
[Lactic acidosis and biguanides: coincidence or negligence of prescribing guidelines].
Topics: Acidosis, Lactic; Biguanides; Drug Prescriptions; Guidelines as Topic; Hypoglycemic Agents; Metformin | 2003 |
Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents.
Topics: Animals; Antimalarials; Biguanides; Catalytic Domain; Cathepsin B; Chloroquine; Homeostasis; Hypoglycemic Agents; Lysosomes; Metals; Metformin; Proguanil; Protease Inhibitors; Rats; Zinc | 2003 |
[Oral treatment of diabetes mellitus. Clinical experience of Metformin or Phenformin alone and combined treatment with these biguanides and P-607].
Topics: Administration, Oral; Biguanides; Chlorpropamide; Diabetes Mellitus; Humans; Metformin; Phenformin | 1962 |
[BIGUANIDES AND SULFONAMIDES IN SMALL DOSES IN THE INITIAL TREATMENT OF THE DIABETES OF THE OBESE PERSON].
Topics: Biguanides; Chlorpropamide; Diabetes Mellitus; Humans; Metformin; Obesity; Sulfanilamide; Sulfanilamides; Sulfonamides | 1963 |
[ATTEMPTED THERAPY OF SEVERE FORMS OF DIABETES MELLITUS WITH A BIGUANIDE PREPARATION "GLUCOPHAGE" (LA 6023)].
Topics: Biguanides; Diabetes Mellitus; Humans; Insulin; Metformin | 1963 |
[EXPERIENCE WITH THE BIGUANIDE "GLUCOPHAGE"].
Topics: Adolescent; Biguanides; Biomedical Research; Geriatrics; Insulin; Metformin; Pharmacology; Toxicology | 1964 |
[ROLE OF BIGUANIDES IN THE TREATMENT OF DIABETES].
Topics: Biguanides; Diabetes Mellitus; Humans; Metformin; Phenformin; Toxicology | 1964 |
[Study of the action of a biguanide (N,N-dimethylguanylguanidine) on a group of 235 diabetic children].
Topics: Amidines; Biguanides; Child; Diabetes Mellitus; Humans; Infant; Metformin | 1960 |
The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight.
Topics: Animals; Antimetabolites; Biguanides; Dipeptidyl Peptidase 4; Enteroendocrine Cells; Fluorouracil; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Hypoglycemic Agents; Intestine, Small; Male; Metformin; Mice; Mice, Inbred BALB C; Organ Size; Peptides; Protease Inhibitors; Pyrroles; Rats; Rats, Inbred F344; Valine | 2004 |
Metformin: preventable lactic acidosis.
Topics: Acidosis, Lactic; Biguanides; Diabetes Mellitus, Type 2; Female; France; Humans; Male; Metformin | 2007 |
Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Biguanides; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Electron Transport; Electron Transport Complex I; Electron Transport Complex II; Enzyme Activation; Glucose; Hypoglycemic Agents; Insulin-Secreting Cells; Metformin; Mice; Mitochondria; Multienzyme Complexes; NADP; Oxidation-Reduction; Phenformin; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Succinates; Tetrazolium Salts; Thiazoles; Time Factors | 2007 |
Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biguanides; Cell Line; Cimetidine; Drug Design; Famotidine; Histamine H2 Antagonists; Humans; Ion Transport; Kinetics; Metformin; Organic Cation Transport Proteins; Phenformin; Ranitidine; Rats; Tetraethylammonium | 2007 |
Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
Topics: Biguanides; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Approval; Drug Combinations; Drug Synergism; Europe; Humans; Hypoglycemic Agents; Metformin; Pyrazines; Sitagliptin Phosphate; Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination; Sulfonylurea Compounds; Triazoles | 2009 |
Determination of metformin and other biguanides in forensic whole blood samples by hydrophilic interaction liquid chromatography-electrospray tandem mass spectrometry.
Topics: Acetonitriles; Autopsy; Biguanides; Chromatography, Liquid; Forensic Sciences; Humans; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Linear Models; Metformin; Methanol; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2012 |
Liver uptake of biguanides in rats.
Topics: Animals; Biguanides; Biological Transport, Active; Biotransformation; Cells, Cultured; Hepatocytes; Hypoglycemic Agents; Liver; Male; Metformin; Phenformin; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Tissue Distribution | 2011 |
Relevance of the OCT1 transporter to the antineoplastic effect of biguanides.
Topics: Adenylate Kinase; Antineoplastic Agents; Biguanides; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Metformin; Organic Cation Transporter 1; Ovarian Neoplasms; Phenformin; RNA, Small Interfering | 2011 |
Central anti-diabetic action of biguanide and thizolidinediones in D-glucose fed and streptozotocin-treated mouse models.
Topics: Animals; Biguanides; Blood Glucose; Brain; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Hypoglycemic Agents; Injections, Intraventricular; Injections, Spinal; Metformin; Mice; Mice, Inbred ICR; Pioglitazone; Rosiglitazone; Streptozocin; Thiazolidinediones | 2012 |
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP.
Topics: Adenylyl Cyclases; AMP-Activated Protein Kinases; Animals; Biguanides; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Type 2; Enzyme Activation; Glucagon; Glucose; Hepatocytes; Hypoglycemic Agents; Liver; Metformin; Mice; Phenformin; Phosphorylation; Signal Transduction | 2013 |
Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism.
Topics: Adenylate Kinase; Aging; Animals; Biguanides; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Caloric Restriction; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Escherichia coli; Folic Acid; Humans; Hypoglycemic Agents; Longevity; Metagenome; Metformin; Methionine; Transcription Factors | 2013 |
Patenting carboxyformin in the United States: how does it work and what does it mean?
Topics: Biguanides; Biomedical Research; Diabetes Mellitus, Type 2; Drug Approval; Humans; Hypoglycemic Agents; Intellectual Property; Legislation, Drug; Metformin; Patents as Topic; United States | 2013 |
Biguanides inhibit complex I, II and IV of rat liver mitochondria and modify their functional properties.
Topics: Animals; Biguanides; Dose-Response Relationship, Drug; Electron Transport Complex I; Electron Transport Complex II; Electron Transport Complex IV; Enzyme Inhibitors; Male; Metformin; Mitochondria, Liver; Phenformin; Rats; Rats, Wistar | 2014 |
Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes.
Topics: Adrenergic beta-Antagonists; Aged; Atherosclerosis; Biguanides; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diuretics; Female; Heart Failure; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prevalence; Risk Factors | 2013 |
Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.
Topics: Aminoimidazole Carboxamide; Biguanides; Cell Line, Transformed; Cell Line, Tumor; Citric Acid Cycle; Endoplasmic Reticulum; Folic Acid; Glycerophosphates; Glycolysis; Humans; Lactates; Metabolome; Metformin; Neoplastic Stem Cells; Nucleotides; Phenformin; Ribonucleotides; src-Family Kinases; Tamoxifen | 2014 |
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria.
Topics: Animals; Antimalarials; Antineoplastic Agents; Biguanides; Cattle; Diabetes Mellitus, Type 2; Electron Transport Complex I; Hep G2 Cells; Humans; Metformin; Mitochondria, Heart; Mitochondria, Liver; Mitochondrial Proton-Translocating ATPases; Oxidative Phosphorylation; Plasmodium; Proguanil; Rats; Reperfusion Injury; Triazines | 2014 |
Metformin and respiratory chain complex I: the last piece of the puzzle?
Topics: Animals; Biguanides; Electron Transport Complex I; Humans; Metformin; Mitochondria, Heart; Mitochondria, Liver; Oxidative Phosphorylation | 2014 |
Serine deprivation enhances antineoplastic activity of biguanides.
Topics: Animals; Biguanides; Cell Line, Tumor; Glycolysis; Humans; Metformin; Mice; Neoplasms; Oxidative Phosphorylation; Phenformin; Serine; Xenograft Model Antitumor Assays | 2014 |
Maintenance of mouse hematopoietic stem cells ex vivo by reprogramming cellular metabolism.
Topics: Aerobiosis; AMP-Activated Protein Kinases; Animals; Biguanides; Cell Differentiation; Cells, Cultured; Cellular Reprogramming; Enzyme Activation; Enzyme Inhibitors; Glycolysis; Hematopoietic Stem Cells; Hypoglycemic Agents; Metformin; Mice; Oxygen Consumption; PTEN Phosphohydrolase | 2015 |
A PET Tracer for Renal Organic Cation Transporters, ¹¹C-Metformin: Radiosynthesis and Preclinical Proof-of-Concept Studies.
Topics: Animals; Autoradiography; Biguanides; Dose-Response Relationship, Drug; Edetic Acid; Isotope Labeling; Kidney; Liver; LLC-PK1 Cells; Metformin; Methylation; Organic Cation Transport Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Swine; Tissue Distribution | 2016 |
Uptake, translocation and possible biodegradation of the antidiabetic agent metformin by hydroponically grown Typha latifolia.
Topics: Biguanides; Biodegradation, Environmental; Hydroponics; Hypoglycemic Agents; Metformin; Plant Leaves; Plant Roots; Rhizome; Typhaceae | 2016 |
Synthesis and Evaluation of 1-Substituted-Biguanide Derivatives as Anti-Diabetic Agents for Type II Diabetes Insulin Resistant.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biguanides; Blood Glucose; Cholesterol; Creatinine; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Metformin; Rats; Rats, Wistar; Triglycerides; Urea | 2016 |
Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport.
Topics: Apoptosis; Biguanides; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Electron Transport; Humans; Metformin; Mitochondria; Nitrophenols; Phenformin; Piperazines; Rotenone; Sulfonamides; U937 Cells | 2016 |
L503F variant of carnitine/organic cation transporter 1 efficiently transports metformin and other biguanides.
Topics: Amines; Asian People; Biguanides; Biological Transport, Active; Buformin; Carnitine; Cyclohexanecarboxylic Acids; Ergothioneine; Gabapentin; gamma-Aminobutyric Acid; HEK293 Cells; Humans; Intestinal Absorption; Metformin; Organic Cation Transporter 1; Polymorphism, Single Nucleotide; White People | 2016 |
Extreme Basicity of Biguanide Drugs in Aqueous Solutions: Ion Transfer Voltammetry and DFT Calculations.
Topics: Biguanides; Hydrogen-Ion Concentration; Metformin; Models, Molecular; Phenformin; Quantum Theory; Solutions; Water | 2016 |
NBR2-GLUT1 axis regulates cancer cell sensitivity to biguanides.
Topics: Biguanides; Metformin; Phenformin | 2017 |
New Biguanides as Anti-Diabetic Agents Part I: Synthesis and Evaluation of 1-Substituted Biguanide Derivatives as Anti-Diabetic Agents of Type II Diabetes Insulin Resistant.
Topics: Animals; Biguanides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin Resistance; Lipids; Liver; Metformin; Nitrous Oxide; Rats | 2017 |
Incorporation of a Biguanide Scaffold Enhances Drug Uptake by Organic Cation Transporters 1 and 2.
Topics: 1-Methyl-4-phenylpyridinium; Biguanides; HEK293 Cells; Humans; Liver; Metformin; Organic Cation Transporter 1; Organic Cation Transporter 2 | 2017 |
Metformin: historical overview.
Topics: Biguanides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin | 2017 |
Pharmacological evaluation of metformin and N-benzylbiguanide, a novel analogue of metformin, on the vasopressor responses to adrenergic system stimulation in pithed rats with fructose-induced insulin resistance.
Topics: Adrenergic Agonists; Animals; Biguanides; Blood Glucose; Blood Pressure; Fructose; Heart Rate; Hemodynamics; Insulin; Insulin Resistance; Male; Metformin; Rats; Rats, Wistar; Receptors, Adrenergic; Sympathetic Nervous System | 2017 |
Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production.
Topics: Adipose Tissue, Brown; Animals; Biguanides; Glycerolphosphate Dehydrogenase; Hydrogen Peroxide; Hypoglycemic Agents; Membrane Potential, Mitochondrial; Metformin; Mitochondria; Oxidation-Reduction; Phenformin; Rats; Rats, Wistar; Reactive Oxygen Species; Succinic Acid | 2017 |
New Biguanides as Anti-Diabetic Agents, Part II: Synthesis and Anti-Diabetic Properties Evaluation of 1-Arylamidebiguanide Derivatives as Agents of Insulin Resistant Type II Diabetes.
Topics: Administration, Oral; Animals; Biguanides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Lipids; Liver Function Tests; Male; Metformin; Nitrous Oxide; Rats | 2017 |
Electrochemically Modulated Liquid-Liquid Extraction for Sample Enrichment.
Topics: Biguanides; Chromatography, High Pressure Liquid; Electrochemical Techniques; Hydrophobic and Hydrophilic Interactions; Liquid-Liquid Extraction; Metformin; Phenformin; Quaternary Ammonium Compounds | 2019 |
A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis.
Topics: Acidosis, Lactic; Biguanides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Prognosis | 2019 |
Cardiac Dysfunction Due to Thiamine Deficiency after Hemodialysis for Biguanide-related Lactic Acidosis.
Topics: Acidosis, Lactic; Beriberi; Biguanides; Diabetes Mellitus, Type 2; Heart Diseases; Humans; Hypoglycemic Agents; Metformin; Renal Dialysis; Thiamine; Thiamine Deficiency | 2022 |
Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides.
Topics: Animals; Biguanides; Cryoelectron Microscopy; Electron Transport Complex I; Metformin; Mitochondria | 2023 |
Metformin May Alter the Metabolic Reprogramming in Cancer Cells by Disrupting the L-Arginine Metabolism: A Preliminary Computational Study.
Topics: AMP-Activated Protein Kinases; Antimalarials; Biguanides; Buformin; Creatine; Humans; Metformin; Molecular Docking Simulation; Neoplasms | 2023 |
Risk of Lactic Acidosis in Hospitalized Diabetic Patients Prescribed Biguanides in Japan: A Retrospective Total-Population Cohort Study.
Topics: Acidosis, Lactic; Aged; Aged, 80 and over; Biguanides; Cohort Studies; Diabetes Mellitus; Female; Humans; Inpatients; Japan; Male; Metformin; Retrospective Studies | 2023 |